Peptide ScienceOct 16, 2026 · 1 min read
Peptide Half-Life: Why Molecular Stability Matters
Half-life describes how quickly the concentration of a substance declines under defined conditions.
READ ARTICLESynedica Blog/Issue 73/October 2026
Peptide science, handling and compliance — written plainly
Evidence-led guides on research peptides: purity and COAs, storage and reconstitution, metabolic research, copper peptides and buying safely in Europe.
Reviewed and datedSourced from published literatureTwo in-house review desks
- 73
- Guides
- 6
- Topics
- 2
- Review desks
Latest
Curated
Editor’s picks
Peptide Science01Peptide Receptors: Agonists, Antagonists and Selectivity
Oct 16, 2026 · 1 min read
Peptide Science02Peptide Immunogenicity: Why Immune Responses Matter
Oct 16, 2026 · 1 min read
Peptide Science03Peptide Aggregation: What Happens When Molecules Cluster?
Oct 16, 2026 · 1 min read
Peptide Science04Peptide Bioavailability: Why Route of Administration Changes Research
Oct 16, 2026 · 1 min read
Peptide Science05Peptide Structure–Activity Relationships Explained
Oct 16, 2026 · 1 min read
Peptide Science06Peptide Clinical Trials: Understanding Endpoints and Evidence
Oct 16, 2026 · 1 min read
Top story
Peptide Science
Peptide Bioavailability: Why Route of Administration Changes Research
Bioavailability refers to the proportion of an administered substance that reaches systemic circulation in a measurable form.
Oct 16, 20261 min read
- 02
Peptide Science
Peptide Structure–Activity Relationships Explained
Oct 16, 2026 · 1 min read
- 03
Peptide Science
Peptide Clinical Trials: Understanding Endpoints and Evidence
Oct 16, 2026 · 1 min read
- 04
Peptide Science
Peptide Nomenclature: Reading Amino-Acid Sequences
Oct 16, 2026 · 1 min read
- 05
Peptide Science
Peptides and the Blood–Brain Barrier: Research Challenges
Oct 16, 2026 · 1 min read
- 06
Peptide Science
Peptide Research Reproducibility: Controls and Reporting
Oct 16, 2026 · 1 min read
From the review desks
“A certificate of analysis is only useful if you know which numbers to read first.”
Buying & Compliance
Where Is Synedica? Inside the Synedica Europe Distribution Network
ReadBuying & Compliance
Synedica Labs Explained: What the Brand Is and How Its European Operation Works
ReadMetabolic Research
Retatrutide Research in Europe: How Trials, Regulators and Evidence Fit Together in 2026
ReadFrom the Synedica catalogue
See allMore from the Blog
Peptide Profiles
PT-141 (Bremelanotide): What the Evidence Really Shows
Bremelanotide is one of the few melanocortin peptides that completed phase 3 trials and reached approval — but only in one country, for one narrow indication. Here is what the trials found, what they did not, and why research material is not the medicine.
Oct 9, 20267 min read
Peptide Profiles
MOTS-c: Promise and Limits of a Mitochondrial Peptide
MOTS-c — often misspelled online — changed how scientists think about mitochondrial DNA. Animal results are striking, but no controlled human trial has shown a clinical benefit. This review explains why that gap matters.
Oct 9, 20267 min read
Peptide Profiles
TB-500 and Thymosin Beta-4: Evidence, Gaps and Risks
TB-500 is often presented as if it were thymosin beta-4. It is not. This review explains what the full protein has shown in early clinical studies, why that evidence does not transfer to the synthetic fragment, and what the risks and rules are.
Oct 9, 20267 min read
Peptide Profiles
Tesamorelin: An Approved GHRH Analogue and Its Evidence
Tesamorelin is one of the clearest examples of a peptide that is a real, approved medicine — but for one condition, in specific markets. This review covers what the trials showed, the safety profile and where the evidence stops.
Oct 9, 20267 min read